Irinotecan Liposomes
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Irinotecan Liposomes, covering 2024-09-05 to 2024-09-05. Get the full timeline:
Most recent: Clinical Trial Update: A PhaseⅠ/Ⅱ Study of Simmitinib or Irinotecan Liposomes Combined With DP303c in Gastric Adenocarcinoma or Gastroesophageal Junction Adenocarcinoma [Phase 1, Phase 2]